Survey shows patients with diabetes who follow doctor's advice more likely to undergo diabetic retinopathy examinations
Diabetic retinopathy is a severe complication of diabetes that can lead to blindness. The Japanese clinical practice ...
Ophthalmology Times4h
Companies results of the combination of Topcon's retinal camera and AEYE Diagnostic Screening
A recent study of AEYE-DS AI technology used in conjunction with the Topcon NW500 resulted in exceptional clinical diagnostic ...
Physician's Weekly4d
Glucose-Lowering Mechanisms of PPARG in Diabetic Retinopathy
The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...
Devdiscourse9d
AI steps up in the battle against diabetes complications
AI has demonstrated considerable potential in diabetic foot (DF) management. AI-powered thermal imaging and predictive ...
Business Wire10d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced ...
Knowridge Science Report1d
Eye problems linked to popular diabetes and weight loss drugs
Doctors at the University of Utah’s Moran Eye Center have reviewed cases of nine patients who developed vision problems while ...
With FDA approval, Genentech turns eye implant's focus to diabetes
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
Medscape2d
Bone-Derived Hormone Predicts Diabetic Kidney Disease Risk
Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, a recent observational study found.
PharmExec9d
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...